Since the publication of the tumor-agnostic cohort of LIBRETTO-001, additional case reports of activity in non-NSCLC and non-thyroid RET-altered cancers have emerged, including in tumor types which were not previously represented in the LIBRETTO-001 data set. Here, RET is linked to cancer.